Murine peritoneal exudate cells (PEC) treated with murine recombinant interferon-gamma (IFN-gamma) (greater than 99% estimated purity), or concanavalin A-stimulated spleen cell supernatants developed tumoricidal properties (macrophage activation factor [MAF] activity). MAF activity was found to occur with treatments of 10 U/ml IFN-gamma, and at levels as low as 1 U/ml IFN-gamma if a second signal (5 ng/ml endotoxin) was present in the MAF assay. Endotoxin (lipopolysaccharide [LPS]) alone at these levels failed to induce MAF; induction of MAF was observed at 1,000-fold greater levels. The ability of IFN-gamma to stimulate murine PEC was species specific. Various sources of materials that displayed MAF activity, including supernatants from interleukin 2-dependent cloned cytotoxic murine T lymphocyte lines that did not display detectable antiviral activity, were neutralized by antibody raised and affinity purified against recombinant IFN-gamma. Thus, IFN-gamma, although never detectable by antiviral assays, appears to be present in many lymphokine preparations and has potent macrophage activation capability.
Skip Nav Destination
Article navigation
1 March 1984
Article|
March 01 1984
Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
L P Svedersky
,
C V Benton
,
W H Berger
,
E Rinderknecht
,
R N Harkins
,
M A Palladino
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1984) 159 (3): 812–827.
Citation
L P Svedersky, C V Benton, W H Berger, E Rinderknecht, R N Harkins, M A Palladino; Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.. J Exp Med 1 March 1984; 159 (3): 812–827. doi: https://doi.org/10.1084/jem.159.3.812
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement